Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antitumor prodrugs for ADEPT from Pharmachemie

Feb. 6, 1997

Tanabe Seiyaku discloses novel antinephritic compounds

Feb. 6, 1997

Magainin analogues reported by Scripps

Feb. 6, 1997

Pollakiuria treatment described by SS Pharm.

Feb. 6, 1997

Japanese researchers develop new HIV protease inhibitors

Feb. 6, 1997

Cell migration inhibitors from Teijin

Feb. 6, 1997

Cephems in development at Meiji Seika

Feb. 6, 1997

5-HT4 antagonists disclosed by Taisho

Feb. 6, 1997

Abbott's newest dopaminergic compounds described in patent literature

Feb. 6, 1997

IL-6 antagonists from Daicel

Feb. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...